Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Earnings

Review historical estimates and see whether a company has beaten or missed expectations.

Last Close
Jul 12 04:00PM ET
9.72
Dollar change
+1.21
Percentage change
14.22
%
IndexRUT P/E- EPS (ttm)-2.48 Insider Own49.34% Shs Outstand20.88M Perf Week-21.42%
Market Cap209.95M Forward P/E- EPS next Y-1.98 Insider Trans-0.06% Shs Float10.94M Perf Month1.78%
Income-52.01M PEG- EPS next Q-0.55 Inst Own31.87% Short Float18.79% Perf Quarter-46.27%
Sales42.09M P/S4.99 EPS this Y-26.75% Inst Trans-5.10% Short Ratio5.76 Perf Half Y-65.83%
Book/sh3.07 P/B3.17 EPS next Y21.60% ROA-45.45% Short Interest2.06M Perf Year-38.52%
Cash/sh3.71 P/C2.62 EPS next 5Y- ROE-62.70% 52W Range6.40 - 33.13 Perf YTD-69.08%
Dividend Est.- P/FCF- EPS past 5Y-27.17% ROI-53.83% 52W High-70.67% Beta1.16
Dividend TTM- Quick Ratio10.87 Sales past 5Y64.84% Gross Margin83.21% 52W Low51.88% ATR (14)1.21
Dividend Ex-Date- Current Ratio12.18 EPS Y/Y TTM-19.31% Oper. Margin-126.34% RSI (14)46.62 Volatility26.70% 12.41%
Employees200 Debt/Eq0.46 Sales Y/Y TTM59.59% Profit Margin-123.58% Recom1.67 Target Price13.80
Option/ShortYes / Yes LT Debt/Eq0.46 EPS Q/Q-90.12% Payout- Rel Volume1.46 Prev Close8.51
Sales Surprise-5.72% EPS Surprise-92.17% Sales Q/Q34.98% EarningsMay 01 Avg Volume357.13K Price9.72
SMA20-10.63% SMA504.01% SMA200-44.68% Trades Volume522,705 Change14.22%
Date Action Analyst Rating Change Price Target Change
Jul-11-24Reiterated Lake Street Buy $18 → $12
May-01-24Resumed Craig Hallum Buy $30 → $23
May-01-24Downgrade William Blair Outperform → Mkt Perform
May-01-24Downgrade JP Morgan Overweight → Neutral $36 → $13
Jan-31-23Initiated Lake Street Buy $20
Jul-18-22Initiated Craig Hallum Buy $15
Jul-26-21Initiated William Blair Outperform
Jul-26-21Initiated Piper Sandler Overweight $26
Jul-26-21Initiated Canaccord Genuity Buy $30
Jul-12-24 11:54AM
Jun-25-24 06:50AM
Jun-06-24 05:48AM
May-22-24 08:30AM
May-16-24 07:30AM
10:45AM Loading…
May-01-24 10:45AM
08:39AM
07:42AM
07:31AM
Apr-30-24 08:56PM
05:44PM
04:34PM
04:05PM
Apr-19-24 11:14AM
Apr-16-24 04:30PM
07:30AM Loading…
Apr-15-24 07:30AM
Jan-31-24 08:00AM
Jan-27-24 11:10AM
Jan-26-24 07:14AM
Jan-25-24 05:45PM
04:50PM
04:39PM
04:05PM
Jan-22-24 12:00PM
Jan-11-24 04:30PM
08:50AM
Jan-08-24 08:30AM
Dec-27-23 04:30PM
07:18AM
Dec-26-23 08:05AM
12:00PM Loading…
Dec-18-23 12:00PM
Dec-08-23 08:50AM
Dec-04-23 07:14AM
Nov-16-23 05:50AM
Nov-15-23 04:21PM
Nov-06-23 08:50AM
Nov-03-23 08:00AM
Oct-31-23 12:00PM
Oct-27-23 09:03AM
08:37AM
Oct-26-23 06:26PM
06:05PM
05:05PM
04:15PM
Oct-12-23 04:30PM
Jul-27-23 08:30AM
Jul-25-23 06:05PM
04:57PM
04:15PM
Jul-11-23 04:30PM
Jul-10-23 10:29AM
Jul-03-23 07:12AM
Jun-27-23 09:55AM
Jun-22-23 04:30PM
09:55AM
May-25-23 08:30AM
Apr-27-23 05:35PM
04:28PM
04:15PM
Apr-20-23 04:30PM
Mar-25-23 08:23AM
Mar-21-23 04:24PM
11:02AM
Mar-16-23 08:30AM
Feb-21-23 11:12AM
08:41AM
07:00AM
Feb-12-23 07:10AM
Jan-31-23 07:56AM
Jan-30-23 10:07AM
Jan-26-23 06:25PM
04:15PM
Jan-12-23 05:30PM
Jan-09-23 08:45AM
Dec-28-22 08:30AM
Dec-20-22 04:05PM
Nov-16-22 08:00AM
Nov-03-22 10:31AM
08:30AM
Nov-01-22 06:05PM
04:15PM
Oct-18-22 04:30PM
Sep-05-22 08:46AM
Jul-31-22 08:26AM
Jul-29-22 08:30AM
Jul-28-22 05:45PM
04:10PM
Jul-14-22 04:30PM
Jul-12-22 10:49AM
08:30AM
Jun-27-22 09:23AM
Jun-12-22 10:10AM
May-23-22 04:30PM
May-13-22 09:06AM
May-09-22 08:30AM
Apr-25-22 04:05PM
Apr-12-22 04:30PM
Mar-29-22 01:22PM
Feb-25-22 06:27AM
Feb-15-22 04:05PM
CVRx, Inc. engages in developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. It operates through the United States, Germany, and Other Countries geographical segments. The company was founded by Robert S. Kieval and Tyler P. Lipschultz in August 2001 and is headquartered in Minneapolis, MN.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Palmer Craig E.SVP, U.S. SALESMar 25 '24Option Exercise0.249342211,229Mar 27 04:56 PM
JOHNSON & JOHNSON10% OwnerFeb 29 '24Option Exercise0.723,8552,7924,103,430Mar 06 03:42 PM
VERRASTRO PAULCHIEF MKTG & STRAT OFFICERFeb 20 '24Option Exercise5.145,00025,7055,000Feb 22 06:05 PM
VERRASTRO PAULCHIEF MKTG & STRAT OFFICERFeb 20 '24Sale21.912,54555,7482,455Feb 22 06:05 PM
JOHNSON & JOHNSON10% OwnerFeb 16 '24Sale25.813,72596,1424,099,575Mar 06 03:42 PM
Yared NadimCHIEF EXECUTIVE OFFICERJan 29 '24Option Exercise0.246,0001,42226,255Jan 31 04:26 PM
SLATTERY JOSEPH PDirectorDec 28 '23Option Exercise0.501,95098422,145Jan 02 04:57 PM
Behbahani AliDirectorDec 14 '23Option Exercise0.2431675316Dec 18 04:40 PM
Galle LizVP OF GLOBAL CLINICAL RESEARCHOct 16 '23Option Exercise0.24778184778Oct 18 04:51 PM
OASHEIM JAREDCHIEF FINANCIAL OFFICERSep 18 '23Option Exercise3.625,86221,22515,447Sep 20 04:04 PM
VERRASTRO PAULCHIEF MKTG & STRAT OFFICERAug 03 '23Sale18.5562811,6520Aug 07 04:58 PM
VERRASTRO PAULCHIEF MKTG & STRAT OFFICERJul 31 '23Option Exercise5.143,75019,2793,750Aug 02 06:29 PM
VERRASTRO PAULCHIEF MKTG & STRAT OFFICERJul 31 '23Sale17.491,12219,6292,628Aug 02 06:29 PM